Lv1
80 积分 2024-01-07 加入
Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer
4天前
已完结
CALLA trial: immunotherapy in locally advanced cervical cancer
5天前
已完结
Cervical cancer: a new era
18天前
已完结
Tisotumab vedotin effective in recurrent cervical cancer
1个月前
已完结
Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer
1个月前
已完结
VP5-2023: Primary results from BEATcc (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030), a randomised phase III trial of first-line atezolizumab (atezo) combined with a platinum doublet and bevacizumab (bev) for metastatic (stage IVB), persistent or recurrent cervical cancer (R/M CC)
1个月前
已关闭
The long-term outcomes of clinical responders to neoadjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer
1个月前
已完结
The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment
1个月前
已完结
Prevalence of Cervical Cancer and Premalignant Cases Based on Pap Smear Screening in Iran in 2022
2个月前
已完结
Value of inflammatory biomarkers in predicting the prognosis of early small hepatocellular carcinoma after radiofrequency ablation
2个月前
已关闭
皖公网安备34019202002308
